Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 15, 2018
Aeglea BioTherapeutics to Present at UBS Global Healthcare Conference
AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for ...
May 15, 2018
Lysogene Announces the Nomination of Dr Ralph Laufer as Chief Scientific Officer and Member of the Executive Team
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Lysogene (LYS.PA) (FR0013233475 – LYS), a pioneering biopharmaceutical company specializing in gene therapy targeting central nervous system (CNS) diseases, is pleased ...
May 15, 2018
INVENTIVA : First-quarter 2018 financial update
Daix (France), May 15, 2018 - Inventiva S.A. ("Inventiva" or the "Company"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH), systemic sclerosis (SSc) ...
May 15, 2018
Bulletin from Moberg Pharma's AGM 2018
STOCKHOLM, May 15, 2018 /PRNewswire/ -- Moberg Pharma AB's ("Company") Annual General Meeting took place on Tuesday, May 15th, 2018 in the Company´s premises in Bromma. ...
May 15, 2018
BIOPHYTIS Receives Orphan Drug Designation in the United States for Sarconeos in Duchenne Muscular Dystrophy (DMD)
PARIS, May 15, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company specializing in the development of drug candidates to treat age-related degenerative ...
May 15, 2018
Altimmune Announces First Quarter 2018 Financial Results and Provides Corporate Update
GAITHERSBURG, Md., May 15, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three months ended March ...
May 15, 2018
Aileron Therapeutics Announces Changes to Management
CAMBRIDGE, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (ALRN), the clinical-stage leader in the field of stapled peptide therapeutics for cancers and other ...
May 15, 2018
Cormedix Inc. Reports First Quarter Financial Results and Provides Business Update
BERKELEY HEIGHTS, NJ / ACCESSWIRE / May 15, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
May 15, 2018
Oncobiologics Reports Second Quarter Financial Results for Fiscal 2018
CRANBURY, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) today reported financial results and business highlights for its three and six months ended ...
May 15, 2018
Molecular Templates to Present at the UBS Global Healthcare Conference
AUSTIN, Texas, May 15, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of the ...
May 15, 2018
AIT Therapeutics to Present Data from Its Inhaled Nitric Oxide Study in Patients Infected with Mycobacterium Abscessus Complex at the 2018 American Thoracic Society Conference
NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
May 15, 2018
Celyad announces launch of proposed global offering
MONT-SAINT-GUIBERT, Belgium, May 15, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell ...
May 15, 2018
Celyad Announces First Quarter 2018 Business Update
MONT-SAINT-GUIBERT, Belgium, May 15, 2018 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (CYAD), a clinical-stage biopharmaceutical company focused on the development of specialized CAR-T cell ...
May 14, 2018
ADMA Biologics Retires Approximately 8.6 Million Shares Previously Issued to Biotest
RAMSEY, N.J. and BOCA RATON, Fla., May 14, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”) announced today that it has ...
May 14, 2018
iCAD Reports First Quarter 2018 Financial Results
NASHUA, N.H., May 14, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today reported ...
May 14, 2018
Vermillion Reports First Quarter 2017 Financial Results
AUSTIN, Texas, May 14, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its financial results for ...
May 14, 2018
Acer Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
NEWTON, Mass., May 14, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
May 14, 2018
Pfenex Announces Positive Top-Line PF708 Study Results in Osteoporosis Patients, On-Track for Submission of New Drug Application in Third Quarter 2018
SAN DIEGO, May 14, 2018 /PRNewswire/ -- Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® ...
May 14, 2018
Zealand hosts conference call on May 16 at 4 pm CET/10 am EDT to present first quarter results 2018
Copenhagen, May 14, 2017 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 50 78) announces that it will be hosting a conference call on ...
May 14, 2018
CytoSorb® Adds Bilirubin and Myoglobin Reduction to European Union Approved Indications for Use
MONMOUTH JUNCTION, N.J., May 14, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly ...
Page 62 of 138